MENU
+Compare
SNDX
Stock ticker: NASDAQ
AS OF
Aug 6, 04:59 PM (EDT)
Price
$12.90
Change
+$0.33 (+2.63%)
Capitalization
1.08B

SNDX Syndax Pharmaceuticals Forecast, Technical & Fundamental Analysis

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SNDX with price predictions
Aug 05, 2025

Momentum Indicator for SNDX turns positive, indicating new upward trend

SNDX saw its Momentum Indicator move above the 0 level on July 29, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SNDX just turned positive on July 09, 2025. Looking at past instances where SNDX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

SNDX moved above its 50-day moving average on August 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SNDX crossed bullishly above the 50-day moving average on August 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where SNDX advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 237 cases where SNDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where SNDX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SNDX broke above its upper Bollinger Band on August 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SNDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.679) is normal, around the industry mean (18.071). P/E Ratio (0.000) is within average values for comparable stocks, (58.287). SNDX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.533). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (11.468) is also within normal values, averaging (278.010).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SNDX is expected to report earnings to rise 12.82% to -93 cents per share on November 11

Syndax Pharmaceuticals SNDX Stock Earnings Reports
Q3'25
Est.
$-0.94
Q2'25
Beat
by $0.18
Q1'25
Beat
by $0.26
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.09
The last earnings report on August 04 showed earnings per share of -82 cents, beating the estimate of -100 cents. With 2.97M shares outstanding, the current market capitalization sits at 1.08B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCMQX20.10N/A
N/A
HCM Sector Plus I
MKVHX16.19N/A
N/A
MFS International Large Cap Value R6
SCCUX11.37N/A
N/A
Invesco Income Advantage U.S. Fund C
WSMVX25.87N/A
N/A
Wilshire Small Company Value Instl
JRSTX12.18-0.09
-0.73%
JH Adaptive Risk Mgd U.S. Eq T

SNDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with CGON. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+21.10%
CGON - SNDX
52%
Loosely correlated
+3.26%
IDYA - SNDX
52%
Loosely correlated
-3.52%
REPL - SNDX
51%
Loosely correlated
+10.68%
ACLX - SNDX
50%
Loosely correlated
-0.06%
NRIX - SNDX
49%
Loosely correlated
+0.27%
More